White House App Faces Questions Over OneSignal Tracking — As Data Is Sent To Overseas Servers Despite ‘No Filter’ Claims

White House App Faces Questions Over OneSignal Tracking — As Data Is Sent To Overseas Servers Despite ‘No Filter’ Claims

A White House-branded mobile application is facing fresh scrutiny amid claims that it may transmit user location data via a third-party system whose infrastructure extends beyond the United States. What might once have been viewed as a routine piece of political tech has instead prompted a wider debate over how closely government-linked apps should be…

Read More

Iran Warns of Attacks on Apple and Google Amidst Rising Tensions

Iran Warns of Attacks on Apple and Google Amidst Rising Tensions

Iran has issued one of its bluntest threats yet against US interests in the region, warning it will begin targeting American companies operating in West Asia from 1 April. Analysts say the move could mark a serious escalation in already fraught tensions, with tech giants including Microsoft, Google and Apple singled out among a list…

Read More

DHS Rejects Report Claiming ICE Will Conduct Arrests At Marines’ Graduation Ceremony: ‘FAKE NEWS’

DHS Rejects Report Claiming ICE Will Conduct Arrests At Marines’ Graduation Ceremony: ‘FAKE NEWS’

The Department of Homeland Security rejected a report claiming that ICE agents would be looking to arrest undocumented immigrants at a graduation ceremony for marines. “FAKE NEWS. ICE will not be making arrests at the basic training graduation in Paris Island, SC,” the agency said in a social media publication. The report in question noted…

Read More

Eli Lilly to Acquire Centessa Pharmaceuticals for Up to $7.8B in Sleep Drug Mega-Deal, CNTA Stock Soaring 45%

Eli Lilly to Acquire Centessa Pharmaceuticals for Up to .8B in Sleep Drug Mega-Deal, CNTA Stock Soaring 45%

Shares of Centessa Pharmaceuticals plc skyrocketed more than 44% Tuesday after the clinical-stage biotech announced it would be acquired by pharmaceutical giant Eli Lilly and Co. in a deal valued at up to $7.8 billion, giving Lilly a promising pipeline of experimental treatments for sleep-wake disorders. Centessa Pharmaceuticals Centessa stock (NASDAQ: CNTA) surged to around…

Read More